We assisted:

  • Handling all claims for a world-leading pharmaceutical company linked to the use of its Covid-19 vaccine in the Benelux.
  • Large medical device company in product liability litigation
  • Representing a major pharmaceutical complaint in ICC arbitration against a global listed pharmaceutical company. Astellas against claims relating to alleged adverse events of an incontinence drug
  • Boehringer Ingelheim in obtaining a cross-border injunction in the Netherlands against patent infringement by Teva in Portugal
  • Boehringer Ingelheim in its life cycle management for several medicinal products
  • Cosmo Technologies Ltd in ground-breaking appeal proceedings against MEB
  • Eli Lilly in multiple court proceedings initiated by patients relating to an alleged breach of pharmacovigilance duties and and high profile product liability cases
  • Galenicum Health in its cross bordre patent litigation against Insud Pharma
  • Gilead in relation to the launch of its new product SOVALDIā„¢
  • GlaxoSmithKline in high profile product liability cases
  • Heraeus in its global litigation against Biomet Zimmer
  • Medac in the Dutch chapter of cross-border patent litigation initiated by Accord Healthcare Ltd. regarding an auto-inflammatory pharmaceutical drug.
  • Pfizer in defence against claims relating to alleged adverse events of a contraception drug
  • Sanofi Pasteur MSD in various regulatory and compliance matters
  • Stichting DES Centrum on the ground-breaking settlement with pharmaceutical companies relating to the adverse events of DES

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.